Key facts
- This page summarizes Sravan K. Emany's Form 4 filing for IRONWOOD PHARMACEUTICALS INC (IRWD).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 12 Mar 2024, 16:05.
Sravan K. Emany - 08 Mar 2024 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)
- Reporting relationship
- SVP, Chief Financial Officer
- Issuer ticker
- IRWD
- Reported as of
- 08 Mar 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 12 Mar 2024, 16:05:21 UTC
- Prior SEC filing
- 06 Mar 2024
- Next SEC filing
- 20 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Brian Tessler, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Sravan K. Emany filed Form 4 for IRONWOOD PHARMACEUTICALS INC (IRWD) on 12 Mar 2024.
Change
- Previous filing in this sequence was filed on 06 Mar 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IRWD
transaction
Class A Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +37,120
- Change %
- +12%
- Price
- $0.000000
- Shares after
- 338,853
- Date
- 08 Mar 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IRWD
transaction
Derivative
Performance-based Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -37,120
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 08 Mar 2024
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 37,120
- Exercise price
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs) granted on March 8, 2023. The earned PSUs were certified on February 12, 2024, and March 7, 2024, and vested on March 8, 2024.
Footnote F2
Each PSU represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs are earned upon the Issuer's Class A Common Stock achieving a specified price per share.
Footnote F3
Additional PSUs may vest upon the Issuer's Class A Common Stock achieving specified prices per share beyond the previously achieved vesting targets.